Does BOTULINUM TOXIN TYPE A Cause Decreased appetite? 182 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 182 reports of Decreased appetite have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 4.9% of all adverse event reports for BOTULINUM TOXIN TYPE A.
182
Reports of Decreased appetite with BOTULINUM TOXIN TYPE A
4.9%
of all BOTULINUM TOXIN TYPE A reports
166
Deaths
171
Hospitalizations
How Dangerous Is Decreased appetite From BOTULINUM TOXIN TYPE A?
Of the 182 reports, 166 (91.2%) resulted in death, 171 (94.0%) required hospitalization, and 167 (91.8%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for BOTULINUM TOXIN TYPE A.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Decreased appetite Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE